Tema Cardiovascular and Metabolic ETF (HRTS)
- Expense ratio0.76%
- Net assets$55.1M
- Dividend yield1.29%
- 1-year return+16.84%
- Holdings46
HRTS ETF price chart
HRTS quote & trading statistics
HRTS performance
Total return · as of October 18, 2026- YTD+5.48%
- 1 year+16.84%
- 1Y volatility
- 14.84%
- 3Y volatility
- 0.00%
- 3Y Sharpe ratio
- 0.00
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
HRTS top 10 holdings
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.32% |
| 2 | TMO | Thermo Fisher Scientific Inc | 5.75% |
| 3 | MRK | Merck & Company Inc | 4.13% |
| 4 | 0QIU | Novo Nordisk A/S Class B | 3.88% |
| 5 | RHHBY | Roche Holding Ltd ADR | 3.84% |
| 6 | UNH | UnitedHealth Group Incorporated | 3.68% |
| 7 | DHR | Danaher Corporation | 3.37% |
| 8 | RVMD | Revolution Medicines Inc | 3.34% |
| 9 | GILD | Gilead Sciences Inc | 3.31% |
| 10 | BBIO | BridgeBio Pharma Inc | 3.16% |
The top 10 holdings make up 46.8% of the fund (46 holdings in total). As of October 18, 2026.
About Tema Cardiovascular and Metabolic ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
HRTS ETF FAQ
What is the HRTS expense ratio?
Tema Cardiovascular and Metabolic ETF has a net expense ratio of 0.76%, or $76.00 a year for every $10,000 invested.
How much money is in HRTS?
Tema Cardiovascular and Metabolic ETF has about $55.1M in net assets.
What are the top holdings of HRTS?
The largest positions in HRTS are Eli Lilly and Company (12.32%), Thermo Fisher Scientific Inc (5.75%), Merck & Company Inc (4.13%). The fund holds 46 securities in total.
How has HRTS performed?
HRTS returned +16.84% over the past year, including reinvested distributions.
Does HRTS pay dividends?
HRTS has a dividend yield of 1.29%.
When was HRTS launched?
Tema Cardiovascular and Metabolic ETF began trading on November 20, 2023.
ETFs similar to HRTS
Funds that track the same index or whose top-10 holdings overlap most with HRTS's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.
| Symbol | Fund | Overlap | Expense ratio | Net assets | 1-year return |
|---|---|---|---|---|---|
| HRTS | Tema Cardiovascular and Metabolic ETF | — | 0.76% | $55.1M | +16.84% |
| RXL | ProShares Ultra Health Care | 58% | 0.93% | $102.7M | +49.40% |
| JDOC | JPMorgan Healthcare Leaders ETF | 52% | 0.68% | $9.4M | +17.75% |
| VHT | Vanguard Health Care ETF | 51% | 0.10% | $19.67B | +23.71% |
| FHLC | Fidelity MSCI Health Care ETF | 50% | 0.07% | $3.54B | +25.78% |